BiodefenseStocks.com Reports on Today’s Technology and Countermeasures Working to Defend against Biowarfare and Bioterrorism.
BiodefenseStocks.com (BS), and HomelandDefenseStocks.com (HDS), investor news portals for the Biodefense and Homeland Security sectors, report on today’s technology and countermeasures working to defend against threats of bioterrorism through an exclusive article – “Countermeasures against Bioterrorism and Biowarfare – Are We Prepared?” Companies participating in the nation’s biodefense efforts include CryoPort (OTC.PK: CYRX), a manufacturer of a disposable cryogenic shipper for infectious materials; Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH), developer of the drug Neumune™ for treatment of Acute Radiation Syndrome (ARS); Aethlon Medical (OTCBB: AEMD), a developer of viral filtration devices that rapidly reduce the presence of infectious disease and toxins in the body; Roaming Messenger (OTCBB: RMSG) an interactive messaging solution provider that enables the delivery of critical information; and MDM Group (OTC.PK: MDDM), a developer of vaccines and screening solutions through their Biodefense Division.
BiodefenseStocks.com and HomelandDefenseStocks.com are investor and industry news portals for the biodefense and homeland security sector. The BS and HDS websites do not make recommendations, but offer unique free information portals to research news, exclusive articles, interviews, investor conferences and a growing list of participating public companies in these sectors.
Report Excerpt: Countermeasures against Bioterrorism and Biowarfare – Are We Prepared?
By Ann-Marie Fleming
As the Homeland Security Department increases the priority level placed on bioterrorism, and the government pushes forward in the development of Project BioShield, the necessity for evolved and adaptive technology and methods to prevent and resolve such threats, becomes a major focus for National Security and the industry at large.
Security Secretary Michael Chertoff recently presented the results of the Department of Homeland Security’s Second Stage Review, which consists of an evaluation of the Department’s operations, policies and structures. Subsequent to the release of the results of this review, a renewed sense of priority regarding the nation’s ability to detect biological attacks became apparent. As Chertoff states, “we must also prepare for terror attacks of even greater consequence -- attacking transit systems with biological, radiological or chemical agents. We now have in place a network of bio-sensors, but we will accelerate the development and deployment of the next generation technology in bio-sensors to more quickly detect biological, radiological, and chemical attacks.”
According to a report by Civitas Group, “In terms of the severity of consequences, the threat of a terrorist attack against the homeland involving a nuclear or biological weapon is the most worrisome scenario facing the United States today.” With that said, the report revealed that the biological sensor market is still fairly undeveloped, but is experiencing significant forward progression as a result of the government’s focus on such technology and biological threats. According to Mark Shaheen, a Principal at the Civitas Group, “The Second Stage Review indicates the intention of the Department to take a more significant role in biodefense, as evidenced by Chertoff's creation of a Chief Medical Officer who will be a direct, more senior official with responsibility for biodefense issues at the department; this is a positive sign.”
Government programs such as Project Bioshield that was implemented to help spark participation in biodefense from the private sector, and in particular from biotechnology and pharmaceutical companies, has further emphasized the prioritization of the threat level associated with bioterrorism. However, Mr. Shaheen explains, while there is significant market potential for biosensors, the impact of BioShield is yet to be fully determined.
Participating Public Companies:
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH), Aethlon Medical (OTCBB: AEMD), MDM Group (OTC.PK: MDDM), CryoPort (OTC.PK: CYRX), Roaming Messenger (OTCBB: RMSG)
(HDS and BS are compensated for Featured companies on portals - see disclaimer for details)
BiodefenseStocks.com includes public companies in the sector and industry information on Bioterrorism, Agriterrorism, Vaccines, Countermeasures to Bioterrorism, Biological & Chemical Detection, Emergency Response and Preparedness, Biological, Chemical, and Radiological News.
HomelandDefenseStocks.com includes a growing list of public companies in the sector. Click here for a partial list of companies involved in homeland defense and security technology and solutions in Airport Security, Biodefense, Biometrics, Defense, Internet Security, Integrated Security, Military, Border and Port Security.